Nkarta Inc (NKTX)
2.45
+0.01
(+0.41%)
USD |
NASDAQ |
Nov 22, 16:00
2.48
+0.03
(+1.22%)
After-Hours: 20:00
Nkarta Shareholders Equity (Quarterly): 430.87M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 430.87M |
June 30, 2024 | 453.18M |
March 31, 2024 | 473.65M |
December 31, 2023 | 273.28M |
September 30, 2023 | 296.82M |
June 30, 2023 | 317.98M |
March 31, 2023 | 346.65M |
December 31, 2022 | 372.21M |
September 30, 2022 | 399.26M |
June 30, 2022 | 421.04M |
Date | Value |
---|---|
March 31, 2022 | 228.71M |
December 31, 2021 | 250.97M |
September 30, 2021 | 270.01M |
June 30, 2021 | 288.38M |
March 31, 2021 | 305.99M |
December 31, 2020 | 321.22M |
September 30, 2020 | 334.98M |
June 30, 2020 | -83.89M |
March 31, 2020 | 26.12M |
December 31, 2019 | -25.48M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-83.89M
Minimum
Jun 2020
473.65M
Maximum
Mar 2024
285.10M
Average
311.98M
Median
Shareholders Equity (Quarterly) Benchmarks
AMN Healthcare Services Inc | 890.66M |
Moderna Inc | 11.93B |
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 2.912M |
IGC Pharma Inc | 7.377M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 532.03M |
Total Liabilities (Quarterly) | 101.16M |